Hepion Pharmaceuticals (HEPA)
(Delayed Data from NSDQ)
$0.67 USD
-0.04 (-6.00%)
Updated Sep 24, 2024 11:23 AM ET
NA Value
NA Growth NA Momentum NA VGMHepion Pharmaceuticals, Inc. (HEPA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$30.00 | $30.00 | $30.00 | 4,125.35% |
Price Target
Only one analyst offered a short-term price target of $30.00 for Hepion Pharmaceuticals, Inc. This represents an increase of 4% from the last closing price of $0.71.
Analyst Price Targets (1 )
Broker Rating
Hepion Pharmaceuticals, Inc. does not currently have any recommendation from brokerage firms.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | NA | NA | NA | NA | NA |
Buy | NA | NA | NA | NA | NA |
Hold | NA | NA | NA | NA | NA |
Sell | NA | NA | NA | NA | NA |
Strong Sell | NA | NA | NA | NA | NA |
ABR | NA | NA | NA | NA | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | NA |
ABR (Last week) | NA |
# of Recs in ABR | NA |
Average Target Price | $30.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | NA |